1. Academic Validation
  2. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations

Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations

  • Hum Mutat. 2008 Jul;29(7):959-65. doi: 10.1002/humu.20746.
Nicole Revencu 1 Laurence M Boon John B Mulliken Odile Enjolras Maria Rosa Cordisco Patricia E Burrows Philippe Clapuyt Frank Hammer Josée Dubois Eulalia Baselga Francesco Brancati Robin Carder José Miguel Ceballos Quintal Bruno Dallapiccola Gayle Fischer Ilona J Frieden Maria Garzon John Harper Jennifer Johnson-Patel Christine Labrèze Loreto Martorell Harriet J Paltiel Annette Pohl Julie Prendiville Isabelle Quere Dawn H Siegel Enza Maria Valente Annet Van Hagen Liselot Van Hest Keith K Vaux Asuncion Vicente Lisa Weibel David Chitayat Miikka Vikkula
Affiliations

Affiliation

  • 1 Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Brussels, Belgium.
Abstract

Capillary malformation-arteriovenous malformation (CM-AVM) is a newly recognized autosomal dominant disorder, caused by mutations in the RASA1 gene in six families. Here we report 42 novel RASA1 mutations and the associated phenotype in 44 families. The penetrance and de novo occurrence were high. All affected individuals presented multifocal capillary malformations (CMs), which represent the hallmark of the disorder. Importantly, one-third had fast-flow vascular lesions. Among them, we observed severe intracranial AVMs, including vein of Galen aneurysmal malformation, which were symptomatic at birth or during infancy, extracranial AVM of the face and extremities, and Parkes Weber syndrome (PKWS), previously considered sporadic and nongenetic. These fast-flow lesions can be differed from the other two genetic AVMs seen in hereditary hemorrhagic telangiectasia (HHT) and in Phosphatase and tensin homolog (PTEN) hamartomatous tumor syndrome. Finally, some CM-AVM patients had neural tumors reminiscent of neurofibromatosis type 1 or 2. This is the first extensive study on the phenotypes associated with RASA1 mutations, and unravels their wide heterogeneity.

Figures